These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 30570353

  • 1. Galactose-Deficient IgA1-Specific Antibody Recognizes GalNAc-Modified Unique Epitope on Hinge Region of IgA1.
    Yamasaki K, Suzuki H, Yasutake J, Yamazaki Y, Suzuki Y.
    Monoclon Antib Immunodiagn Immunother; 2018 Dec; 37(6):252-256. PubMed ID: 30570353
    [Abstract] [Full Text] [Related]

  • 2. Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy.
    Yasutake J, Suzuki Y, Suzuki H, Hiura N, Yanagawa H, Makita Y, Kaneko E, Tomino Y.
    Nephrol Dial Transplant; 2015 Aug; 30(8):1315-21. PubMed ID: 26109484
    [Abstract] [Full Text] [Related]

  • 3. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis.
    Suzuki H, Yasutake J, Makita Y, Tanbo Y, Yamasaki K, Sofue T, Kano T, Suzuki Y.
    Kidney Int; 2018 Mar; 93(3):700-705. PubMed ID: 29329643
    [Abstract] [Full Text] [Related]

  • 4. Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy.
    Zhang K, Li Q, Zhang Y, Shang W, Wei L, Li H, Gao S, Yan T, Jia J, Liu Y, Lin S.
    Kidney Blood Press Res; 2019 Mar; 44(5):1196-1206. PubMed ID: 31574506
    [Abstract] [Full Text] [Related]

  • 5. Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy.
    Zhao L, Peng L, Yang D, Chen S, Lan Z, Zhu X, Yuan S, Chen G, Liu Y, Liu H.
    Clin Immunol; 2020 Aug; 217():108483. PubMed ID: 32479989
    [Abstract] [Full Text] [Related]

  • 6. Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy.
    Lee M, Suzuki H, Kato R, Fukao Y, Nakayama M, Kano T, Makita Y, Suzuki Y.
    CEN Case Rep; 2021 Feb; 10(1):17-22. PubMed ID: 32676896
    [Abstract] [Full Text] [Related]

  • 7. Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.
    Gomes MM, Suzuki H, Brooks MT, Tomana M, Moldoveanu Z, Mestecky J, Julian BA, Novak J, Herr AB.
    Biochemistry; 2010 Jul 13; 49(27):5671-82. PubMed ID: 20507092
    [Abstract] [Full Text] [Related]

  • 8. Humoral immunity against the proline-rich peptide epitope of the IgA1 hinge region in IgA nephropathy.
    Kokubo T, Hashizume K, Iwase H, Arai K, Tanaka A, Toma K, Hotta K, Kobayashi Y.
    Nephrol Dial Transplant; 2000 Jan 13; 15(1):28-33. PubMed ID: 10607764
    [Abstract] [Full Text] [Related]

  • 9. IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA1.
    Suzuki H, Moldoveanu Z, Hall S, Brown R, Julian BA, Wyatt RJ, Tomana M, Tomino Y, Novak J, Mestecky J.
    Contrib Nephrol; 2007 Jan 13; 157():129-33. PubMed ID: 17495450
    [Abstract] [Full Text] [Related]

  • 10. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.
    Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J.
    J Clin Invest; 1999 Jul 13; 104(1):73-81. PubMed ID: 10393701
    [Abstract] [Full Text] [Related]

  • 11. Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.
    Wada Y, Matsumoto K, Suzuki T, Saito T, Kanazawa N, Tachibana S, Iseri K, Sugiyama M, Iyoda M, Shibata T.
    PLoS One; 2018 Jul 13; 13(11):e0206865. PubMed ID: 30388165
    [Abstract] [Full Text] [Related]

  • 12. Measurement of galactosyl-deficient IgA1 by the monoclonal antibody KM55 contributes to predicting patients with IgA nephropathy with high risk of long-term progression.
    Martín-Penagos L, Fernández-Fresnedo G, Benito-Hernández A, Mazón J, de Cos M, Oviedo MV, San Segundo D, López-Hoyos M, Gómez-Román J, Ruiz JC, Rodrigo E.
    Nefrologia (Engl Ed); 2021 Jul 13; 41(3):311-320. PubMed ID: 33741175
    [Abstract] [Full Text] [Related]

  • 13. Clinical Significance of Serum Galactose-Deficient IgA1 Level in Children with IgA Nephropathy.
    Irabu H, Shimizu M, Kaneko S, Inoue N, Mizuta M, Ohta K, Yachie A.
    J Immunol Res; 2020 Jul 13; 2020():4284379. PubMed ID: 32537466
    [Abstract] [Full Text] [Related]

  • 14. N-acetylgalactosaminide α2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathy.
    Stuchlova Horynova M, Vrablikova A, Stewart TJ, Takahashi K, Czernekova L, Yamada K, Suzuki H, Julian BA, Renfrow MB, Novak J, Raska M.
    Nephrol Dial Transplant; 2015 Feb 13; 30(2):234-8. PubMed ID: 25281698
    [Abstract] [Full Text] [Related]

  • 15. Measurement of galactosyl-deficient IgA1 by the monoclonal antibody KM55 contributes to predicting patients with IgA nephropathy with high risk of long-term progression.
    Martín-Penagos L, Fernández-Fresnedo G, Benito-Hernández A, Mazón J, de Cos M, Oviedo MV, San Segundo D, López-Hoyos M, Gómez-Román J, Ruiz JC, Rodrigo E.
    Nefrologia (Engl Ed); 2021 Feb 13; 41(3):311-320. PubMed ID: 36166247
    [Abstract] [Full Text] [Related]

  • 16. Glomerular galactose-deficient IgA1 expression analysis in pediatric patients with glomerular diseases.
    Ishiko S, Horinouchi T, Fujimaru R, Shima Y, Kaito H, Tanaka R, Ishimori S, Kondo A, Nagai S, Aoto Y, Sakakibara N, Nagano C, Yamamura T, Yoshimura M, Nakanishi K, Fujimura J, Kamiyoshi N, Nagase H, Yoshikawa N, Iijima K, Nozu K.
    Sci Rep; 2020 Aug 20; 10(1):14026. PubMed ID: 32820208
    [Abstract] [Full Text] [Related]

  • 17. Glomerular Galactose-Deficient IgA1(KM55) Positive May Predict Poorer Prognosis in Coexisting Primary Membranous Nephropathy and IgA Nephropathy Patients.
    Cheng W, Wang G, Guo W, Sun L, Xu X, Dong H, Ye S, Geng Y, Cheng H.
    Cells; 2022 Dec 28; 12(1):. PubMed ID: 36611910
    [Abstract] [Full Text] [Related]

  • 18. Specificity of two monoclonal antibodies against a synthetic glycopeptide, an analogue to the hypo-galactosylated IgA1 hinge region.
    Hiki Y, Hori H, Yamamoto K, Yamamoto Y, Yuzawa Y, Kitaguchi N, Takahashi K.
    J Nephrol; 2015 Apr 28; 28(2):181-6. PubMed ID: 25037591
    [Abstract] [Full Text] [Related]

  • 19. A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy.
    Sugiyama M, Wada Y, Kanazawa N, Tachibana S, Suzuki T, Matsumoto K, Iyoda M, Honda H, Shibata T.
    PLoS One; 2020 Apr 28; 15(4):e0232194. PubMed ID: 32324811
    [Abstract] [Full Text] [Related]

  • 20. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG.
    Tomana M, Matousovic K, Julian BA, Radl J, Konecny K, Mestecky J.
    Kidney Int; 1997 Aug 28; 52(2):509-16. PubMed ID: 9264010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.